Process of synthesizing substituted pyridine and pyrimidine compound

US10316033B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10316033-B2
Application numberUS-201615561003-A
CountryUS
Kind codeB2
Filing dateMar 24, 2016
Priority dateMar 25, 2015
Publication dateJun 11, 2019
Grant dateJun 11, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided is a process of synthesizing a substituted pyridine and pyrimidine compound. Particularly, provided is a method for preparing a compound of formula III via a compound of formula II′, wherein the definition of each of groups is as described as the description. Compound with other methods, the method in the present invention has features of high yield and a result product being easier to separate.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for preparing compound of formula III: (7) Reacting a compound of formula II′ with methylamine or the salt thereof to provide the compound of formula III; wherein R 1 , R 2 , R 3 and R 4 are each independently selected from the group consisting of substituted or unsubstituted C 1 -C 4 alkyl, substituted or unsubstituted —COO—C 1 -C 4 alkyl, or substituted or unsubstituted —OC(O)—C 1 -C 4 alkyl; or R 1 , R 2 and the adjacent —N— together form a substituted or unsubstituted 3-10 membered heterocycle, and the heterocycle may contain 1-3 heteroatoms selected from the group consisting of N, O or S; the 3-10 membered heterocycle is monocycle, bicycle, spirocycle or bridged ring; or R 3 , R 4 and the adjacent —N— together constitute a substituted or unsubstituted 3-10 membered heterocycle, and the heterocycle may contain 1-3 heteroatoms selected from the group consisting of N, O or S; the 3-10 membered heterocycle is monocycle, bicycle, spirocycle or bridged ring; R 5 is selected from the group consisting of C1-C4 alkoxy, chlorine atom, bromine atom, hydroxyl, or the substitution is that one or more hydrogen atoms on a group are replaced by substituents selected from the group consisting of halogens, C 1 -C 4 alkyl; wherein the methylamine or the salt thereof is selected from the group consisting of methylamine alcohol solution, methylamine aqueous solution, methylamine hydrochloride, or methylamine sulfate. 2. The method of claim 1 , wherein, the method further optionally comprises the step: reacting the compound of formula II to provide the compound of formula II′; wherein, R is selected from the group consisting of C 1 -C 4 alkyl; and RO— and R 5 — are different groups. 3. The method of claim 2 , wherein, in the method, the compound of formula II is prepared by the following step (6): (6) reacting a compound of formula I with a compound of formula IIa or the salt thereof in an inert solvent to provide the compound of formula II; wherein: X is selected from Cl or Br; R 1 , R 2 , R 3 , and R 4 are each independently selected from the group consisting of substituted or unsubstituted C 1 -C 4 alkyl, substituted or unsubstituted C 1 -C 4 ester group; or R 1 , R 2 and adjacent —N— together form a substituted or unsubstituted 3-10 membered heterocycle, and the heterocycle may contain 1-3 heteroatoms selected from the group consisting of N, O or S; the 3-10 membered heterocycle is monocycle, bicycle, spirocycle or bridged ring; or R 3 , R 4 and adjacent —N— together constitute a substituted or unsubstituted 3-10 membered heterocycle, and the heterocycle may contain 1-3 heteroatoms selected from the group consisting of N, O or S; the 3-10 membered heterocycle is monocycle, bicycle, spirocycle or bridged ring; the substitution is that one or more hydrogen atoms on a group are replaced by substituents selected from the group consisting of alkyl groups of halogens and C 1 -C 4 alkyl. 4. The method of claim 3 , wherein, in the method, the compound of formula I is prepared by the following step (5): (5) reacting a compound of formula 4 with a compound of formula Ia or the salt thereof in the inert solvent to provide the compound of formula I; wherein: X is selected from Cl or Br; R 1 , R 2 are each independently selected from the group consisting of substituted or unsubstituted C 1 -C 4 alkyl, substituted or unsubstituted C 1 -C 4 ester group; or R 1 , R 2 and adjacent —N— together form a substituted or unsubstituted 3-10 membered heterocycle, and the heterocycle may contain 1-3 heteroatoms selected from the group consisting of N, O or S; the 3-10 membered heterocycle is monocycle, bicycle, spirocycle or bridged ring; the substituted means one or more hydrogen atoms on a group are replaced by substituents selected from the group consisting of halogen, and C 1 -C 4 alkyl. 5. The method of claim 4 , wherein, in the method, the compound of formula 4 is prepared by the following step (4): (4) reacting a compound of formula 3 with halogenated reagent to provide the compound of formula 4, where X is selected from Cl or Br. 6. The method of claim 5 , wherein, in the method, the compound of formula 3 is prepared by the step (3): (3) reacting a compound of formula 2 with 6-aminouracil to provide the compound of formula 3. 7. The method of claim 6 , wherein in the method, the compound of formula 2 is prepared by the following step (2): (2) reacting a compound of formula 1 with DMF-DMA in inert solvents to provide the compound of formula 2. 8. A method for preparing a compound of formula A: comprising the step: (7a) reacting a compound of formula 6 with methylamine to provide the compound of formula A wherein R is a C 1 -C 4 alkyl. 9. A method for preparing a compound of formula 6, comprising the steps: (5a) reacting a compound of formula 4 with 3-oxa-8-azabicyclo[3.2.1]octane hydrochloride in an inert solvent to provide a compound of formula 5; (6a) reacting the compound of formula 5 with 3-(S)-3-methylmorpholine in an inert solvent to provide the compound of formula 6, wherein R is C1-C4 alkyl. 10. A method for preparing a compound of formula B comprising the step: (7b) reacting a compound of formula 8 with methylamine to provide the compound of formula B, wherein R is C 1 -C 4 alkyl. 11. The method of claim 1 , wherein R5 is selected from the group consisting of methoxyl, ethoxy, chlorine atom, bromine atom, hydroxyl, and 12. The method of any one of claims 2-10, wherein R is selected from the group consisting of methyl or ethyl. 13. The method of claim 1 , wherein the methylamine or the salt thereof is methylamine methanol solution, methylamine ethanol solution. 14. The method of claim 1 , wherein the methylamine or the salt thereof is methylamine methanol solution.

Assignees

Inventors

Classifications

  • C07D471/04Primary

    Ortho-condensed systems · CPC title

  • C07D519/00Primary

    Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00 · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10316033B2 cover?
Provided is a process of synthesizing a substituted pyridine and pyrimidine compound. Particularly, provided is a method for preparing a compound of formula III via a compound of formula II′, wherein the definition of each of groups is as described as the description. Compound with other methods, the method in the present invention has features of high yield and a result product being easier to…
Who is the assignee on this patent?
Shanghai Inst Materia Medica Cas, Shandong Luoxin Pharmacy Stock
What technology area does this patent fall under?
Primary CPC classification C07D471/04. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).